You just read:

Forge Therapeutics And Evotec Present Efficacy Data For LpxC Inhibitor In Urinary Tract, Lung, Thigh, And Abdominal Infection Models At ASM ESCMID 2017

News provided by

Forge Therapeutics, Inc.

Sep 07, 2017, 08:00 ET